2ND GEN CENTRIMAG PRIMARY CONSOLE
Device
Abbott Laboratories
Total Payments
$549,022
Transactions
2,388
Doctors
1,094
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $148,851 | 722 | 431 |
| 2023 | $148,386 | 674 | 427 |
| 2022 | $251,784 | 992 | 477 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $311,369 | 153 | 56.7% |
| Food and Beverage | $144,252 | 2,085 | 26.3% |
| Consulting Fee | $51,739 | 57 | 9.4% |
| Travel and Lodging | $15,132 | 67 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,350 | 13 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $8,000 | 3 | 1.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,074 | 9 | 1.3% |
| Education | $106.00 | 1 | 0.0% |
Payments by Type
Research
$311,369
153 transactions
General
$237,653
2,235 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CentriMag Failure-to-Wean Post Approval Study | Abbott Laboratories | $285,950 | 0 |
| CentriMag Failure-to-Wean Post-Approval Study | Abbott Laboratories | $25,420 | 0 |
Top Doctors Receiving Payments for 2ND GEN CENTRIMAG PRIMARY CONSOLE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Greeley, CO | $319,812 | 162 |
| , M.D | Critical Care Medicine | Oklahoma City, OK | $10,004 | 19 |
| , M.D | Internal Medicine | Sacramento, CA | $9,964 | 37 |
| , MD | Cardiovascular Disease | East Meadow, NY | $7,406 | 18 |
| , CRNP | Acute Care | Oklahoma City, OK | $7,334 | 32 |
| , MD, MS | Internal Medicine | San Francisco, CA | $7,228 | 21 |
| , MD | Surgery | Dallas, TX | $6,853 | 24 |
| , M.D | Student in an Organized Health Care Education/Training Program | Albuquerque, NM | $4,263 | 19 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Falls Church, VA | $4,200 | 5 |
| , MD | Anesthesiology | Oklahoma City, OK | $2,907 | 34 |
| , D.O | Cardiovascular Disease | Hartford, CT | $2,750 | 7 |
| , MD | Cardiovascular Disease | Oak Lawn, IL | $2,700 | 3 |
| , MD | Surgery | Los Angeles, CA | $2,617 | 5 |
| , MD | Internal Medicine | Concord, NC | $2,548 | 5 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Los Angeles, CA | $2,537 | 17 |
| , MD | Cardiovascular Disease | Dallas, TX | $2,439 | 4 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | San Francisco, CA | $2,400 | 2 |
| , MSN, RN, PCNS-BC | Pediatrics | Dallas, TX | $2,207 | 12 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Detroit, MI | $2,200 | 2 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Robbinsville, NJ | $2,074 | 3 |
| , AGACNP-BC | Acute Care | Dallas, TX | $2,046 | 24 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Austin, TX | $1,967 | 23 |
| , MD | Transplant Surgery | Dallas, TX | $1,758 | 3 |
| , MD | Cardiovascular Disease | New York, NY | $1,750 | 2 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | Washington, DC | $1,700 | 2 |
Ad
Manufacturing Companies
- Abbott Laboratories $549,022
Product Information
- Type Device
- Total Payments $549,022
- Total Doctors 1,094
- Transactions 2,388
About 2ND GEN CENTRIMAG PRIMARY CONSOLE
2ND GEN CENTRIMAG PRIMARY CONSOLE is a device associated with $549,022 in payments to 1,094 healthcare providers, recorded across 2,388 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $148,851 was paid across 722 transactions to 431 doctors.
The most common payment nature for 2ND GEN CENTRIMAG PRIMARY CONSOLE is "Unspecified" ($311,369, 56.7% of total).
2ND GEN CENTRIMAG PRIMARY CONSOLE is associated with 2 research studies, including "CentriMag Failure-to-Wean Post Approval Study" ($285,950).